Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
7.4
5.2
Journals
Cancers
Special Issues
Optimizing Surgical Procedures and Outcomes in Renal Cancer
share announcement

Optimizing Surgical Procedures and Outcomes in Renal Cancer

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Clinical Research of Cancer".

Deadline for manuscript submissions: 20 December 2024 | Viewed by 636

Special Issue Editors

Prof. Dr. Maciej Salagierski

E-Mail Website
Guest Editor
Urology Department, Faculty of Medicine and Health Science, University of Zielona Gora, Zielona Gora, Poland
Interests: renal cell carcinoma
Dr. Piotr Kania

E-Mail Website
Guest Editor
St. John Paul II Mazovian Provincial Hospital in Siedlce, Siedlce, Poland
Interests: laparoscopic urology; robotics & minimally invasive urology; urinary incontinence; urodynamics; urolithiasis; urogynecology & female urology; endourology; urologic oncology

Special Issue Information

Dear Colleagues,

We are delighted to announce the call for submissions to a Special Issue of Cancers focusing on the topic of "Optimizing Surgical Procedure and Outcomes in Renal Cancer". Renal cancer, particularly kidney cancer, is a significant health concern worldwide. The management of renal cancer requires careful consideration of surgical procedures to achieve optimal outcomes for patients.

This Special Issue aims to provide a comprehensive overview of the current knowledge and advancements in surgical procedures for renal cancer, with a particular focus on optimizing outcomes. We invite the submission of original research articles and reviews that cover various aspects of renal cancer surgery, including, but not limited to:

  1. Minimally invasive treatment options: the use of minimally invasive techniques, such as radiofrequency ablation (RFA), microwave ablation (MWA), and cryoablation (CA), in the management of kidney cancer.
  1. Surgical innovations: novel surgical approaches, including robotic-assisted surgery and laparoscopic procedures, for the treatment of renal cancer.
  1. Surgical planning and techniques: strategies for preoperative planning, intraoperative navigation, and surgical techniques to improve surgical precision and outcomes in renal cancer surgery.
  1. Patient selection and outcomes: identification of factors that influence patient selection for different surgical approaches and evaluation of short-term and long-term outcomes following renal cancer surgery.
  1. Multidisciplinary approaches: collaborative efforts involving urologists, radiologists, pathologists, and oncologists to optimize surgical decision making and postoperative management for renal cancer patients.

All submitted articles will undergo a rigorous peer review process to ensure the highest scientific quality and relevance to the field. We encourage contributions from researchers, clinicians, and experts in the field of renal cancer research and urology.

By consolidating the latest research findings and clinical experiences, we aim to enhance our understanding of renal cancer surgery and promote the development of strategies for optimizing surgical procedures and outcomes. We believe that your valuable contributions will significantly contribute to the success of this Special Issue.

Should you have any questions, require further information, or need any assistance, please do not hesitate to reach out to us. We are here to support and facilitate your participation in this Special Issue.

Thank you for your attention to this matter, and we look forward to receiving your valuable submissions.

Prof. Dr. Maciej Salagierski
Dr. Piotr Kania
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • renal cancer surgery
  • optimizing outcomes
  • minimally invasive techniques
  • surgical innovations
  • multidisciplinary approaches

Published Papers (1 paper)

Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

10 pages, 243 KiB  
Article
Perioperative and Oncological Outcomes of Percutaneous Radiofrequency Ablation versus Partial Nephrectomy for cT1a Renal Cancers: A Retrospective Study on Groups with Similar Clinical Characteristics
by Milosz Jasinski, Przemyslaw Wisniewski, Marta Bielinska, Jerzy Siekiera, Krzysztof Kamecki and Maciej Salagierski
Cancers 2024, 16(8), 1528; https://doi.org/10.3390/cancers16081528 - 17 Apr 2024
Viewed by 473
Abstract
Over the recent years, progress in imaging techniques has led to an increased detection of kidney tumours, including small renal masses. While surgery is still the standard of care, there is a growing interest in minimally invasive methods. Ultrasound (US)-guided percutaneous ablation is [...] Read more.
Over the recent years, progress in imaging techniques has led to an increased detection of kidney tumours, including small renal masses. While surgery is still the standard of care, there is a growing interest in minimally invasive methods. Ultrasound (US)-guided percutaneous ablation is particularly attractive because it is a safe and relatively simple procedure. In this study, we investigated the results of US-guided percutaneous radiofrequency ablation (RFA) and partial nephrectomy (PN) in the treatment of cT1a renal cancers. Between August 2016 and February 2022, 271 patients with renal tumours underwent percutaneous RFA as initial treatment in our institution. In the same period, 396 patients with renal tumours underwent surgical tumour excision. For the purpose of this study, only patients with confirmed renal cancer with matched age and tumour characteristics (size, location) were selected for both groups. Thus, a group of 44 PN patients and 41 RFA patients were formed with the same qualification criteria for both groups. Parameters such as procedure length, blood loss, hospital stay, analgesics used, and pre- and post-procedural serum creatinine were compared between these groups. Patients followed up with contrast-enhanced CT. There was no significant difference in age, tumour size, tumour location, and creatinine levels between these groups. All procedures were generally well tolerated. During a median follow-up of 28 months, two cases of recurrence/residual disease were found in each group. The overall survival was 100% in both groups, and all patients were disease-free at the end of observation. Percutaneous RFA was associated with a significantly shorter procedure length and hospital stay, lower blood loss, and lower analgesics used than PN. In the selected group of renal cancer patients, US-guided percutaneous RFA was associated with a shorter hospital stay, less analgesics used, and a shorter procedure length than PN, without differences in the oncological results or kidney function. Full article
(This article belongs to the Special Issue Optimizing Surgical Procedures and Outcomes in Renal Cancer)
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1
Back to TopTop